Evaluation of aspirin metabolites as inhibitors of hypoxia-inducible factor hydroxylases
作者:Benoit M. Lienard、Ana Conejo-García、Ineke Stolze、Christoph Loenarz、Neil J. Oldham、Peter J. Ratcliffe、Christopher J. Schofield
DOI:10.1039/b814440k
日期:——
Known and potential aspirinmetabolites were evaluated as inhibitors of oxygen-sensing hypoxia-inducible transcription factor (HIF) hydroxylases; some of the metabolites were found to stabilise HIF-α in cells.
Asymmetric synthesis. Metal complex mediated synthesis of chiral glycine by enantioselective proton exchange
作者:Zdravko. Dokuzovic、Nicholas K. Roberts、Jeffery F. Sawyer、John. Whelan、B. Bosnich
DOI:10.1021/ja00268a051
日期:1986.4
On etudie l'echange selectif des protons methylenes d'un coordinat glycine coordine. On montre aussi que la vitesse de l'echange peut etre employee pour produire de la glycine chirale a n'importe quel degre de purete chirale. Le systeme choisi est [Co((S,S)-proam)(picgly)] + un complexe de Co(III) contenant 2 coordinats tridentes dont l'un contient un reste glycine (proam=iminodimethylene-2,2' bis-pyrrolidine;
在 etudie l'echange selectif des protons 亚甲基 d'un coordinat 甘氨酸 coordine。On montre aussi que la vitesse de l'echange peut etre employee pour produire de la Glyine chirale a n'importe quel degre de purete chirale。Le systeme choisi est [Co((S,S)-proam)(picgly)] + un complexe de Co(III) contenant 2 coordinats tridentes dont l'un contient un reste gcine (proam=亚氨基二甲基-2,2' bis-吡咯烷;picgly=N-吡啶甲酰基甘氨酸)
HETEROCYCLIC COMPOUNDS
申请人:Ishichi Yuji
公开号:US20120088748A1
公开(公告)日:2012-04-12
Provided is a compound having a monoamine reuptake inhibitory activity, which is represented by the formula (I)
wherein ring A is an optionally substituted 6-membered aromatic ring, ring B is
the substituents on ring A are optionally bonded to form, together with ring A, an optionally substituted 9- or 10-membered aromatic fused ring, and other symbols are as defined in the specification, or a salt thereof.
[EN] CHEMICAL COMPOUNDS<br/>[FR] COMPOSÉS CHIMIQUES
申请人:ISIS INNOVATION
公开号:WO2015092412A1
公开(公告)日:2015-06-25
A compound which is a pyridine or isoquinoline derivative of formula (I), or a pharmaceutically acceptable salt thereof, which is useful in the inhibition of γ- butyrobetaine hydroxylase (BBOX). The compounds are particularly useful in treatment of cardiovascular disease and diabetes. (I)
Provided is a compound having a monoamine reuptake inhibitory activity, which is represented by the formula (I) wherein ring A is an optionally substituted 6-membered aromatic ring, ring B is the substituents on ring A are optionally bonded to form, together with ring A, an optionally substituted 9- or 10-membered aromatic fused ring, and other symbols are as defined in the specification, or a salt thereof.